Press Releases

Date	Title and Summary	Additional Formats
July 14, 2009	Aastrom Biosciences Receives Notification That NASDAQ to Continue Temporary Suspension of Certain Continued Listing Requirements	View HTML Aastrom Biosciences Receives Notification That NASDAQ to Continue Temporary Suspension of Certain Continued Listing Requirements
June 18, 2009	FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial	View HTML FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
May 22, 2009	Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event	View HTML Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event
May 8, 2009	Aastrom Reports Third Quarter Fiscal Year 2009 Financial Results	View HTML Aastrom Reports Third Quarter Fiscal Year 2009 Financial Results
May 5, 2009	Initial Data From Aastrom's IMPACT-DCM Trial Presented At International Society for Cellular Therapy Annual Meeting by Amit N. Patel, M.D.	View HTML Initial Data From Aastrom's IMPACT-DCM Trial Presented At International Society for Cellular Therapy Annual Meeting by Amit N. Patel, M.D.
March 23, 2009	Aastrom Biosciences Receives Notification That NASDAQ Further Extends Suspension of Certain Continued Listing Requirements	View HTML Aastrom Biosciences Receives Notification That NASDAQ Further Extends Suspension of Certain Continued Listing Requirements
March 10, 2009	Aastrom Commends Expansion of Federal Support for Stem Cell Research	View HTML Aastrom Commends Expansion of Federal Support for Stem Cell Research
March 3, 2009	FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial	View HTML FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
February 6, 2009	Aastrom Reports Second Quarter Fiscal Year 2009 Financial Results	View HTML Aastrom Reports Second Quarter Fiscal Year 2009 Financial Results
February 4, 2009	Aastrom Biosciences to Present At the 11th Annual BIO CEO & Investor Conference	View HTML Aastrom Biosciences to Present At the 11th Annual BIO CEO & Investor Conference

Investor Relations

Press Releases

Company Presentation